EUVIMEDEUVIMED entdecken
Crossref

NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry

Achim Georg Beule, Martin Desrosiers, Tanya M. Laidlaw, Andrew A. White, Eugenio De Corso

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S312-S313

DOI: 10.1055/s-0044-1785055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Achim Georg Beule und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting non-steroidal anti-inflammatory−exacerbated respiratory disease (NSAID-ERD) have more severe CRSwNP and lower quality of life. This study characterizes CRSwNP patients with NSAID-ERD initiating dupilumab in real-world practice.

Methods

AROMA (NCT04959448) is a prospective global registry, recruiting adults with CRSwNP initiating dupilumab. Quality of life assessments included the 22-item Sino-Nasal Outcome Test (SNOT-22; range 0–110) and total symptom score (TSS; 0–9).

Results

As of February 2023, the study had recruited 303 patients (mean [SD] SNOT-22 and TSS of 45.4 [22.2] and 5.4 [2.3], respectively). Among patients self-reporting history of NSAID-ERD (n=78), scores were 46.5 (21.5) and 5.7 (2.2), respectively. Mean (SD) age at NSAID-ERD diagnosis was 39.3 (11.8) years. Of the patients with previous surgery (n=187), 51 (27.3%) had NSAID-ERD. Among all patients with NSAID-ERD, 11 (14.1%) had undergone confirmatory aspirin challenge, 11 (14.1%) aspirin desensitization, and 15 (19.2%) reported adverse reaction to alcohol consumption.

Conclusion

A quarter of adults with CRSwNP initiating dupilumab in AROMA report having NSAID-ERD, many with high disease burden. However, most have not undergone aspirin challenge or desensitization to confirm their diagnosis. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Beule, A. G., Desrosiers, M., Laidlaw, T. M., White, A. A., & Corso, E. D. (2024). NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry. Laryngo-Rhino-Otologie, 103(S 02 S 02), S312-S313. https://doi.org/10.1055/s-0044-1785055

Vancouver

Beule AG, Desrosiers M, Laidlaw TM, White AA, Corso ED. NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S312-S313. doi:10.1055/s-0044-1785055

BibTeX
@article{Beule2024,
  author = {Beule, Achim Georg and Desrosiers, Martin and Laidlaw, Tanya M. and White, Andrew A. and Corso, Eugenio De},
  title = {NSAID-ERD and disease burden among patients with chronic rhinosinusitis with nasal polyps in the AROMA registry},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S312--S313},
  doi = {10.1055/s-0044-1785055}
}
Kostenlos starten →